Clinical Trial Update: A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

View source ↗

Summary

A completed observational trial describing real-world use of bosutinib in the UK and Netherlands for chronic myeloid leukemia, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Bosutinib (bosutinib)

Snippet

Sponsor: Pfizer | Conditions: Chronic Myeloid Leukaemia | Status: COMPLETED | Results posted: 2018-09-13